Apologies, but no results were found. Perhaps searching will help find a related post.
25 March 2015: Download new fact sheets – Kidney Cancer Localised or Kidney Cancer Advanced These factsheets contain information about the different treatment options, follow up care, information relating to the diagnosis such as ‘stages’ and ‘types’ of kidney cancer, and ongoing support and information services. If you would like to speak to someone at Kidney Health […]
5 March 2015: Valuable contribution to understanding of kidney cancer treatment by patients participating in clinical trial. Outcomes of ECOG-ACRIN clinical trial for the treatment of locally advanced RCC in the adjuvant setting: Drugs used in metastatic kidney cancer do not prevent kidney cancer recurring after surgery After surgery to remove cancer, additional ‘adjuvant’ treatments like […]
7 January 2015: The Pharmaceutical Benefits Advisory Committee (PBAC) has approved both Sorafenib and Axitinib for treatment of stage IV (metastatic) clear cell variant renal cell carcinoma (RCC). These treatment options are for patients whose cancers have grown despite previous PBS-subsidised drug treatments (Sunitinib and Pazopanib). There are now five drugs available for Australians suffering […]
24 November 2014: Results have been released from a phase II clinical trial testing the effectiveness of a combination of two existing anticancer drugs, bevacizumab and erlotinib, in treating advanced sporadic papillary renal cell carcinoma (pRCC) and in patients with a highly aggressive form of pRCC called hereditary leiomyomatosis and renal cell cancer (HLRCC). The […]
8 October 2014: Kidney Health Australia recognises the need for further research into rare and less common cancers, including kidney cancer, and also the importance of kidney cancer patients having an active voice in rare cancer research. CART-WHEEL.org is an international, ethically approved website that collects information directly from people who are affected by rare […]